These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10913621)

  • 1. CD44v6 cell surface expression is a common feature of macrophages and macrophage-like cells - implication for a natural macrophage extravasation mechanism mimicked by tumor cells.
    Braumüller H; Gansauge S; Ramadani M; Gansauge F
    FEBS Lett; 2000 Jul; 476(3):240-7. PubMed ID: 10913621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.
    Takazoe K; Foti R; Tesch GH; Hurst LA; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Clin Exp Immunol; 2000 Sep; 121(3):523-32. PubMed ID: 10971520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma.
    Gansauge F; Gansauge S; Rau B; Scheiblich A; Poch B; Schoenberg MH; Beger HG
    Cancer; 1997 Nov; 80(9):1733-9. PubMed ID: 9351541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44v6 correlates with cell proliferation and cellular atypia in urothelial carcinoma cell lines 5637 and HT1197.
    Kuncová J; Kostrouch Z; Viale M; Revoltella R; Mandys V
    Folia Biol (Praha); 2005; 51(1):3-11. PubMed ID: 15783086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
    Liu YJ; Yan PS; Li J; Jia JF
    World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD44v6 gene in normal human peripheral blood.
    Song J; Zhang DS; Zheng J
    World J Gastroenterol; 2005 Jun; 11(23):3591-4. PubMed ID: 15962382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
    Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
    Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant expression of CD44 in preneoplastic lesions of the lung.
    Wimmel A; Kogan E; Ramaswamy A; Schuermann M
    Cancer; 2001 Sep; 92(5):1231-6. PubMed ID: 11571737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cytokines on the expression of fas ligand and CD44 splice variants in colon carcinoma cells.
    Wimmenauer S; Steiert A; Wolff-Vorbeck G; Xing B; Baier PK; Rückauer KD; Kirste G; von Kleist S
    Tumour Biol; 1999; 20(6):294-303. PubMed ID: 10567875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages.
    Kirkpatrick RB; Emery JG; Connor JR; Dodds R; Lysko PG; Rosenberg M
    Exp Cell Res; 1997 Nov; 237(1):46-54. PubMed ID: 9417865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities.
    Seiter S; Schmidt DS; Zöller M
    Int Immunol; 2000 Jan; 12(1):37-49. PubMed ID: 10607748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1.
    McIntire RH; Morales PJ; Petroff MG; Colonna M; Hunt JS
    J Leukoc Biol; 2004 Dec; 76(6):1220-8. PubMed ID: 15459235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of calcitonin mRNA expression to the differentiation state of HL 60 cells.
    Kiefer P; Bacher M; Pflüger KH
    Leuk Lymphoma; 1994 May; 13(5-6):501-7. PubMed ID: 7520792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
    Levesque MC; Haynes BF
    J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer.
    Bendardaf R; Elzagheid A; Lamlum H; Ristamäki R; Collan Y; Pyrhönen S
    Oncol Rep; 2005 May; 13(5):831-5. PubMed ID: 15809746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of leukocyte adherence-related glycoproteins during differentiation of HL-60 promyelocytic leukemia cells.
    Hickstein DD; Smith A; Fisher W; Beatty PG; Schwartz BR; Harlan JM; Root RK; Locksley RM
    J Immunol; 1987 Jan; 138(2):513-9. PubMed ID: 2947951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.
    Amirghofran Z; Asiaee E; Kamazani FM
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
    Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
    Dong WG; Sun XM; Yu BP; Luo HS; Yu JP
    World J Gastroenterol; 2003 Nov; 9(11):2596-600. PubMed ID: 14606105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.